prof. dr. J.L. (Hans) Hillege
Cardiology
Telephone:
E-mail:
h.hillege umcg.nl
Research
1 - 23 out of 23Page size: 50
- Streng, K. W. (2019). Non-cardiac comorbidities in heart failure with preserved ejection fraction: Focussing on obesity and renal dysfunction. University of Groningen.
- Pang, C. (2018). Computational methods for data discovery, harmonization and integration: Using lexical and semantic matching with an application to biobanking phenotypes. University of Groningen.
- Demissei, B. G. (2017). Optimizing clinical risk stratification in acute heart failure. University of Groningen.
- Kraai, I. (2017). Patient-reported outcomes in patients with heart failure. Rijksuniversiteit Groningen.
- Ploegstra, M-J. (2017). Prognostic factors, treatment goals and clinical endpoints in pediatric pulmonary arterial hypertension. Rijksuniversiteit Groningen.
- Douwes, J. M. (2017). Shaping the future of paediatric pulmonary arterial hypertension. Rijksuniversiteit Groningen.
- Cao, Q. (2016). Towards optimal decision making in personalized medicine: Potential value assessment of biomarkers in heart failure exemplars. University of Groningen.
- Barents, M. (2015). Chronic heart failure diagnostics and application of neuropeptides in residential elderly. University of Groningen.
- Valente, M. (2015). Diuretic response and cardiorenal interaction in heart failure. [S.n.].
- Schroten, N. (2015). New roles for renin in heart failure and cardio-renal interaction. [S.n.].
- Beyer, A. R-M. (2015). The human dimension in the assessment of medicines: Perception, preferences, and decision making in the European regulatory environment. University of Groningen.
- Mahmoud, K. (2014). Symptom onset and treatment in acute myocardial infarction. [S.n.].
- de Vries, A. E. (2013). The use of computer decision support and telemonitoring in heart failure. [s.n.].
- Szymanski, M. K. (2012). Cardiorenal interaction : experimental and clinical studies. [S.n.].
- Valkenhoef, G. H. M. V. (2012). Making better use of clinical trials: computational decision support methods for evidence-based drug benefit-risk assessment. s.n.
- Linssen, G. C. M. (2011). BNP and NT-proBNP in cardiovascular disease. [s.n.].
- Loon, R. L. E. V. (2010). Paediatric pulmonary hypertension: epidemiology, characterisation and treatment. s.n.
- Damman, K. (2009). Cardiorenal interaction in heart failure. s.n.
- Geluk, C. A. (2008). Coronary risk stratification: from PREVEND to the prevention of coronary events. [s.n.].
- Borggreve, S. E. (2008). The role of CETP and HDL metabolism in cardiac disease. [S.n.].
- Verhave, J. C. (2004). The impact of albuminuria and cardiovascular risk factors on renal function. s.n.
ID: 85102